Stocks Major Rally July: 3 Stocks to Watch for July Gains
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
What Affects Stock Index Levels
Index levels move with price changes, weighting shifts, and market events. This overview highlights the main drivers behind index fluctuations.
20,883 articles
Velocity Financial 2025 Earnings: What Investors Know
As velocity financial readies its quarterly release, investors seek clues about growth, profitability, and risk. This...
Covered-Call MSTY Caps Your Gains, Risks Rise for Investors
A synthetic covered‑call ETF on MicroStrategy stock continues to pay outs through monthly distributions, yet the stra...
When UWM Walked Away From Harbors: A Shareholder Win
A fierce bidding war over Two Harbors tested UWM's strategy. This article explains why UWM walked away from harbors c...
What Make Adviser's Ocular Signals for VR Adviser Trades
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
Chevron Produces Million Barrels: Is It Time to Buy?
Chevron sits at the heart of today’s energy debate: steady production, looming supply gaps, and the question every in...
Shares Intel Have Plummeted: Is This a Buy Opportunity?
Tech stocks can swing fast. When shares intel have plummeted, investors must separate noise from fundamentals. This g...
Might Consider Investment Dollar: A Practical Guide for 2026
Dollar Tree has reshaped its business with store expansion and a strategic divestment. This guide explains why you mi...
Magnificent Seven Done Reporting: Top 3 Buys Now
The quarter is over and the magnificent seven done reporting. Here are three buys that stand out for ambitious invest...
Chevron Will Explore Pipeline: What It Means for Investors
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
From Crisis 459% Gain: Intel's Bold Turnaround Now
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status